Optimizing Clinical Trials for Exosome & Extra-Cellular Vesicle Therapies & Scaling Manufacturing & Analytical Testing to Accelerate Regulatory Approval, Maximize Investments & De-Risk Platform Development
As landmark clinical programs from pioneers including RION and Capricor Therapeutics progress beyond early-stage development, the exosome therapeutics field is entering a transformative era. Growing clinical validation, expanding therapeutic applications, and increasing investor confidence are accelerating exosomes from a promising modality to a commercially viable therapeutic platform. With regulatory scrutiny rising and development complexity increasing, the industry faces a critical opportunity to establish the manufacturing, analytical, and clinical foundations needed to bring exosome-based medicines to patients at scale.
Bringing together experts across Discovery & Translational Science, CMC & Manufacturing, Analytical Development, Clinical Development, Regulatory Affairs, Quality & Commercial Strategy, the 8th Exosome-Based Therapeutics Summit will provide end-to-end insights needed to de-risk development, accelerate clinical progress, and build commercially sustainable exosome therapies.
Uniting senior leaders from pioneering biotech innovators, emerging start-ups, technology enablers, manufacturers, investors, and regulatory stakeholders, this meeting is where the exosome community comes together to overcome today's bottlenecks and define tomorrow's standards.
If you are serious about advancing exosome therapeutics toward approval and commercial success, this is where you need to be.
The Biggest Challenges Facing Exosome Developers
Tackling the Critical Roadblocks to Clinical and Commercial Success
Despite significant scientific progress, exosome therapeutic developers continue to face major challenges on the path to approval and commercialization.
At the summit, discussions are focused on helping teams overcome key industry hurdles, including:
Covering the Full Development Journey for Exosome Therapeutics
Explore the Full Event Guide
- Get a full overview of the agenda, speakers, and sessions in one place
- Preview featured clinical trials that we’ll be shining a light on
- Discover exclusive content such as keynote highlights, attendee benefits and more
- Share easily with colleagues and decision-makers
Official Partners
Expertise Partners
Exhibition Partners
Innovation Partner
Networking since the conference was small but had a critical mass. The sessions were well organized and provided cutting edge science and status of ongoing clinical trials in the exosome space
Kuldeep Neote, Chief Executive Officer, Diadem Biotherapeutics
The size of the conference was great, I especially liked that you got the regulatory person to attend because this is usually the missing part of the discussion that is so crucial to cover
Suvi Aivio, Director- Cell Therapy, Edge Animal Health
Excellent content, good thought-leaders, and easy to build networks”-
Joe Barendt, Senior Director, International Business Development, Daicel USA
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Exosome-Based Therapy Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.